John K S Woo
Overview
Explore the profile of John K S Woo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
840
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan K, Lam W, King A, Lin V, Lee P, Zee B, et al.
NEJM Evid
. 2024 Feb;
2(7):EVIDoa2200309.
PMID: 38320164
BACKGROUND: We previously conducted a prospective study to show that nasopharyngeal cancer (NPC) screening with circulating Epstein–Barr virus (EBV) DNA analysis can improve survival. However, the long-term significance of positive...
2.
King A, Ai Q, Lam W, Tse I, So T, Wong L, et al.
J Natl Cancer Inst
. 2024 Jan;
116(5):665-672.
PMID: 38171488
Background: Although contrast-enhanced magnetic resonance imaging (MRI) detects early-stage nasopharyngeal carcinoma (NPC) not detected by endoscopic-guided biopsy (EGB), a short contrast-free screening MRI would be desirable for NPC screening programs....
3.
Lam W, King A, Miller J, Liu Z, Yu K, Chua M, et al.
J Natl Cancer Inst
. 2023 Feb;
115(4):355-364.
PMID: 36723440
A meeting of experts was held in November 2021 to review and discuss available data on performance of Epstein-Barr virus (EBV)-based approaches to screen for early stage nasopharyngeal carcinoma (NPC)...
4.
Bruce J, To K, Lui V, Chung G, Chan Y, Tsang C, et al.
Nat Commun
. 2022 Jul;
13(1):4353.
PMID: 35896551
No abstract available.
5.
Bruce J, To K, Lui V, Chung G, Chan Y, Tsang C, et al.
Nat Commun
. 2021 Jul;
12(1):4193.
PMID: 34234122
Interplay between EBV infection and acquired genetic alterations during nasopharyngeal carcinoma (NPC) development remains vague. Here we report a comprehensive genomic analysis of 70 NPCs, combining whole-genome sequencing (WGS) of...
6.
Sham C, Van Hasselt C, Chow S, Lee D, Cho R, Woo J, et al.
Laryngoscope
. 2019 Aug;
130(7):1622-1628.
PMID: 31418865
Objectives/hypothesis: This study analyzes the treatment outcomes of frontal inverted papillomas (FIPs) in an attempt to provide guidelines for surgery selection. Study Design: Retrospective case series. Methods: The treatment results...
7.
Lam W, Jiang P, Chan K, Peng W, Shang H, Heung M, et al.
Nat Commun
. 2019 Jul;
10(1):3256.
PMID: 31332191
Epstein-Barr virus (EBV) is associated with a number of diseases, including malignancies. Currently, it is not known whether patients with different EBV-associated diseases have different methylation profiles of circulating EBV...
8.
Ai Q, King A, Chan J, Chen W, Chan K, Woo J, et al.
Eur Radiol
. 2019 Mar;
29(10):5627-5634.
PMID: 30903340
Objectives: MRI can detect early-stage nasopharyngeal carcinoma (NPC), but the detection is more challenging in early-stage NPCs because they must be distinguished from benign hyperplasia in the nasopharynx. This study...
9.
Lam W, Jiang P, Chan K, Cheng S, Zhang H, Peng W, et al.
Proc Natl Acad Sci U S A
. 2018 May;
115(22):E5115-E5124.
PMID: 29760067
Circulating tumor-derived DNA testing for cancer screening has recently been demonstrated in a prospective study on identification of nasopharyngeal carcinoma (NPC) among 20,174 asymptomatic individuals. Plasma EBV DNA, a marker...
10.
Chan K, Woo J, King A, Zee B, Lam W, Chan S, et al.
N Engl J Med
. 2017 Aug;
377(6):513-522.
PMID: 28792880
Background: Circulating cell-free Epstein-Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. We conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to...